TrialThe British journal of ophthalmology2020

Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study.

Marta Sacchetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.